XML 51 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated (Deficit) [Member]
Treasury Stock [Member]
Conversion Labs, Inc. Stockholders' (Deficit) [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2018 $ 457,822 $ 12,744,249 $ (12,140,670) $ (163,701) $ 897,700 $ (77,962) $ 819,738
Balance, shares at Dec. 31, 2018 45,782,305            
Stock issued for services $ 1,000 15,000 16,000 16,000
Stock issued for services, shares 100,000            
Stock compensation $ 10,000 144,600 154,600 154,600
Stock compensation, shares 1,000,000            
Distributions to non-controlling interest (34,298) (34,298)
Net (loss) (663,747) (663,747) (69,816) (733,563)
Balance at Mar. 31, 2019 $ 468,822 12,903,849 (12,804,418) (163,701) 404,552 (182,075) 222,477
Balance, shares at Mar. 31, 2019 46,882,305            
Balance at Dec. 31, 2019 $ 534,037 15,236,396 (16,594,919) (163,701) (988,187) (141,056) (1,129,241)
Balance, shares at Dec. 31, 2019 53,403,649            
Stock compensation 95,900 95,900 95,900
Distributions to non-controlling interest (36,000)
Cashless exercise of warrants $ 7,389 (7,389)
Cashless exercise of warrants, shares 739,291            
Deemed distribution from down-round provision in common stock shares yet to be issued (106,519) (106,519) (106,519)
Deemed distribution from warrant price adjustments 1,142,385 (1,142,385)
Net (loss) (2,394,728) (2,538,307) (138,816) (2,533,544)
Balance at Mar. 31, 2020 $ 541,426 $ 16,467,292 $ (20,238,552) $ (163,701) $ (3,537,114) $ (315,871) $ (3,709,407)
Balance, shares at Mar. 31, 2020 54,142,940